rs773734233
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM1PP3_StrongPP5_Very_Strong
The NM_000071.3(CBS):c.700G>A(p.Asp234Asn) variant causes a missense change. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_000071.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00 AC: 11AN: 127908Hom.: 1 Cov.: 15 FAILED QC
GnomAD3 exomes AF: 0.0000119 AC: 3AN: 251422Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135894
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.0000193 AC: 25AN: 1293816Hom.: 4 Cov.: 28 AF XY: 0.0000186 AC XY: 12AN XY: 644588
GnomAD4 genome Data not reliable, filtered out with message: AS_VQSR AF: 0.0000860 AC: 11AN: 127908Hom.: 1 Cov.: 15 AF XY: 0.000113 AC XY: 7AN XY: 62044
ClinVar
Submissions by phenotype
Classic homocystinuria Pathogenic:1
- -
not provided Pathogenic:1
Not observed at significant frequency in large population cohorts (gnomAD); Published functional studies demonstrated that D234N expression in E. coli cells reduces CBS enzyme activity and D234N expression in Hek 293 cells leads to less soluble and fewer properly assembled subunits, suggesting D234N may lead to an unstable protein that is less able to assemble into a functional enzyme (Casique et al., 2014); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 10338090, 14972327, 22267502, 20303981, 19914636, 16786517, 23981774) -
HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED Pathogenic:1
This sequence change replaces aspartic acid, which is acidic and polar, with asparagine, which is neutral and polar, at codon 234 of the CBS protein (p.Asp234Asn). This variant is present in population databases (rs773734233, gnomAD 0.006%). This missense change has been observed in individual(s) with homocystinuria (PMID: 14972327, 16786517; internal data). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 212852). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt CBS protein function with a positive predictive value of 95%. Experimental studies have shown that this missense change affects CBS function (PMID: 22267502, 23981774). For these reasons, this variant has been classified as Pathogenic. -
Homocystinuria Pathogenic:1
Variant summary: The CBS c.700G>A (p.Asp234Asn) variant causes a missense change located in the CBS N-terminal catalytic domain at a position that is conserved across species (De Luca et al., 2004). This involves a conserved nucleotide with 3/4 in silico tools (SNPs&Go not captured here due to low reliability index) predict a "damaging" outcome, which is further supported with functional studies. The variant of interest was observed in the large, broad control population, ExAC, with an allele frequency of 2/121342 (1/60671), which does not exceed the estimated maximal expected allele frequency for a pathogenic CBS variant of 1/328 (0.0030414). The variant of interest has been reported in multiple affected individuals via publications including 2 homozygous individuals. In addition, multiple reputable databases/clinical laboratories cite the variant as "pathogenic." Therefore, taking all available lines of evidence into consideration, the variant of interest is classified as Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at